AAAAAA

   
Results: 1-11 |
Results: 11
THE ANGINA-RELATED LIMITATIONS AT WORK QUESTIONNAIRE
Authors: LERNER DJ AMICK BC MALSPEIS S ROGERS WH GOMES DRJ SALEM DN
Citation: Dj. Lerner et al., THE ANGINA-RELATED LIMITATIONS AT WORK QUESTIONNAIRE, Quality of life research, 7(1), 1998, pp. 23-32
WARFARIN ANTICOAGULATION AND SURVIVAL - A COHORT ANALYSIS FROM THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION
Authors: ALKHADRA AS SALEM DN RAND WM UDELSON JE SMITH JJ KONSTAM MA
Citation: As. Alkhadra et al., WARFARIN ANTICOAGULATION AND SURVIVAL - A COHORT ANALYSIS FROM THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION, Journal of the American College of Cardiology, 31(4), 1998, pp. 749-753
ANTIPLATELET AGENTS AND SURVIVAL - A COHORT ANALYSIS FROM THE STUDIESOF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) TRIAL
Authors: ALKHADRA AS SALEM DN RAND WM UDELSON JE SMITH JJ KONSTAM MA
Citation: As. Alkhadra et al., ANTIPLATELET AGENTS AND SURVIVAL - A COHORT ANALYSIS FROM THE STUDIESOF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 419-425
ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE
Authors: SALEM DN LEVINE HJ PAUKER SG ECKMAN MH DAUDELIN DH
Citation: Dn. Salem et al., ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE, Chest, 114(5), 1998, pp. 590-601
MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES
Authors: ECKMAN MH LEVINE HJ SALEM DN PAUKER SG
Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 114(5), 1998, pp. 699-714
EFFECT OF ANTIPLATELET AGENTS ON SURVIVAL IN PATIENTS WITH LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION
Authors: ALKHADRA AS SALEM DN RAND WM UDELSON JE SMITH JJ KONSTAM MA
Citation: As. Alkhadra et al., EFFECT OF ANTIPLATELET AGENTS ON SURVIVAL IN PATIENTS WITH LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION, Circulation, 92(8), 1995, pp. 3194-3194
ENHANCED HEPATIC-UPTAKE OF TL-201 IN PATIENTS WITH SEVERE NARROWING OF THE RIGHT CORONARY-ARTERY
Authors: CHUTTANI K METHERALL J GRIFFITH J OATES E KONSTAM MA PAUKER SG SALEM DN UDELSON JE
Citation: K. Chuttani et al., ENHANCED HEPATIC-UPTAKE OF TL-201 IN PATIENTS WITH SEVERE NARROWING OF THE RIGHT CORONARY-ARTERY, The American journal of cardiology, 76(14), 1995, pp. 1020-1024
UTILITY OF IN-VIVO, INTRACARDIAC 2-DIMENSIONAL ECHOCARDIOGRAPHY IN THE ASSESSMENT OF MYOCARDIAL RISK AREA AND MYOCARDIAL DYSSYNERGY DURING CORONARY-OCCLUSION AND REPERFUSION
Authors: SCHWARTZ SL KUSAY BS PANDIAN NG ARONOVITZ M KONSTAM MA SALEM DN
Citation: Sl. Schwartz et al., UTILITY OF IN-VIVO, INTRACARDIAC 2-DIMENSIONAL ECHOCARDIOGRAPHY IN THE ASSESSMENT OF MYOCARDIAL RISK AREA AND MYOCARDIAL DYSSYNERGY DURING CORONARY-OCCLUSION AND REPERFUSION, Echocardiography, 11(1), 1994, pp. 71-78
FAMILIAL LIPOPROTEIN DISORDERS AND PREMATURE CORONARY-ARTERY DISEASE
Authors: SCHAEFER EJ GENEST JJ ORDOVAS JM SALEM DN WILSON PWF
Citation: Ej. Schaefer et al., FAMILIAL LIPOPROTEIN DISORDERS AND PREMATURE CORONARY-ARTERY DISEASE, Atherosclerosis, 108, 1994, pp. 190000041-190000054
CONVERTING-ENZYME INHIBITORS DO NOT INFLUENCE CYTOKINE ANTAGONIST LEVELS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION
Authors: SMITH JJ SHAPIRO L UDELSON JE SALEM DN KONSTAM MA DINARELLO CA
Citation: Jj. Smith et al., CONVERTING-ENZYME INHIBITORS DO NOT INFLUENCE CYTOKINE ANTAGONIST LEVELS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION, Circulation, 88(4), 1993, pp. 294-294
BASE-LINE QUALITY-OF-LIFE PREDICTS MORBIDITY AND MORTALITY IN 5210 PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION (SOLVD PREVENTION AND TREATMENT TRIALS)
Authors: SALEM DN KONSTAM V POULEUR H KOSTIS JB GORKIN L HANDBERG E SHUMAKER SA MOTTARD I WOODS P LINDHOLM L MCBRIDE M YUSUF S
Citation: Dn. Salem et al., BASE-LINE QUALITY-OF-LIFE PREDICTS MORBIDITY AND MORTALITY IN 5210 PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION (SOLVD PREVENTION AND TREATMENT TRIALS), Circulation, 88(4), 1993, pp. 359-359
Risultati: 1-11 |